|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McCarthy CE, Field JK, Rajlawat BP, Field
AE and Marcus MW: Trends and regional variation in the incidence of
head and neck cancers in England: 2002 to 2011. Int J Oncol.
47:204–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Statistics OfNCancer Registration
Statistics. England: 2013, 2015.
|
|
4
|
Langevin SM, Grandis JR and Taioli E:
Female hormonal and reproductive factors and head and neck squamous
cell carcinoma risk. Cancer Lett. 310:216–221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bae JM: Modifiable risk factors of lung
cancer in ‘never-smoker’ women. Epidemiol Health. 37:e20150472015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang BJ, Zhang B, Yan SS, Li ZC, Jiang T,
Hua CJ, Lu L, Liu XZ, Zhang DH1, Zhang RS, et al: Hormonal and
reproductive factors and risk of esophageal cancer in women: A
meta-analysis. Dis Esophagus. 29:448–454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Green J, Roddam A, Pirie K, Kirichek O,
Reeves G and Beral V: Million Women Study collaborators:
Reproductive factors and risk of oesophageal and gastric cancer in
the Million Women Study cohort. Br J Cancer. 106:210–216. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Freedman ND, Lacey JV Jr, Hollenbeck AR,
Leitzmann MF, Schatzkin A and Abnet CC: The association of
menstrual and reproductive factors with upper gastrointestinal
tract cancers in the NIH-AARP cohort. Cancer. 116:1572–1581. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bosetti C, Negri E, Franceschi S, Conti E,
Levi F, Tomei F and La Vecchia C: Risk factors for oral and
pharyngeal cancer in women: A study from Italy and Switzerland. Br
J Cancer. 82:204–207. 2000.PubMed/NCBI
|
|
10
|
Gallus S, Bosetti C, Franceschi S, Levi F,
Simonato L, Negri E and La Vecchia C: Oesophageal cancer in women:
Tobacco, alcohol, nutritional and hormonal factors. Br J Cancer.
85:341–345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu H, Liu G, Zhao P and Zhu L: Hormonal
and reproductive factors and risk of esophageal cancer in Chinese
postmenopausal women: A case-control study. Asian Pac J Cancer
Prev. 12:1953–1956. 2011.PubMed/NCBI
|
|
12
|
Chen ZH, Shao JL, Lin JR, Zhang X and Chen
Q: Reproductive factors and oesophageal cancer in Chinese women: A
case-control study. BMC Gastroenterol. 11:492011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lindblad M, García Rodríguez LA, Chandanos
E and Lagergren J: Hormone replacement therapy and risks of
oesophageal and gastric adenocarcinomas. Br J Cancer. 94:136–141.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gallus S, Bosetti C, Franceschi S, Levi F,
Negri E and La Vecchia C: Laryngeal cancer in women: Tobacco,
alcohol, nutritional, and hormonal factors. Cancer Epidemiol
Biomarkers Prev. 12:514–517. 2003.PubMed/NCBI
|
|
15
|
Pokoradi AJ, Iversen L and Hannaford PC:
Factors associated with age of onset and type of menopause in a
cohort of UK women. Am J Obstet Gynecol. 205:34.e1–34.e13. 2011.
View Article : Google Scholar
|
|
16
|
Faubion SS, Kuhle CL, Shuster LT and Rocca
WA: Long-term health consequences of premature or early menopause
and considerations for management. Climacteric. 18:483–491. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Monterrosa-Castro A, Blümel JE,
Portela-Buelvas K, Mezones-Holguín E, Barón G, Bencosme A, Benítez
Z, Bravo LM, Calle A, Chedraui P, et al: Collaborative Group for
Research of the Climacteric in Latin America (REDLINC): Type II
diabetes mellitus and menopause: A multinational study.
Climacteric. 16:663–672. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stott-Miller M, Chen C, Chuang SC, Lee YC,
Boccia S, Brenner H, Cadoni G, Dal Maso L, La Vecchia C, Lazarus P,
et al: History of diabetes and risk of head and neck cancer: A
pooled analysis from the International Head and Neck Cancer
Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev.
21:294–304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu Y, Yue D, Yuan B, Zhu L and Lu M:
Reproductive factors are associated with oesophageal cancer risk:
Results from a meta-analysis of observational studies. Eur J Cancer
Prev. 26:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Camargo MC, Goto Y, Zabaleta J, Morgan DR,
Correa P and Rabkin CS: Sex hormones, hormonal interventions, and
gastric cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers
Prev. 21:20–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dietrich K, Demidenko E, Schned A, Zens
MS, Heaney J and Karagas MR: Parity, early menopause and the
incidence of bladder cancer in women: A case-control study and
meta-analysis. Eur J Cancer. 47:592–599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suba Z: Gender-related hormonal risk
factors for oral cancer. Pathol Oncol Res. 13:195–202. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takács D, Koppány F, Mihályi S and Suba Z:
Decreased oral cancer risk by moderate alcohol consumption in
non-smoker postmenopausal women. Oral Oncol. 47:537–540. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zong H, Xu H, Geng Z, Ma C, Ming X, Shang
M, Li K, He X, Du H, Zhao J, et al: Reproductive factors in
relation to risk of brain tumors in women: An updated meta-analysis
of 27 independent studies. Tumour Biol. 35:11579–11586. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang B, Lv J, Li Y, Yuan S, Wang Z and He
S: Relationship between female hormonal and menstrual factors and
pancreatic cancer: A meta-analysis of observational studies.
Medicine. 94:e1772015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Caini S, Gibelli B, Palli D, Saieva C,
Ruscica M and Gandini S: Menstrual and reproductive history and use
of exogenous sex hormones and risk of thyroid cancer among women: A
meta-analysis of prospective studies. Cancer Causes Control.
26:511–518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arem H, Park Y, Felix AS, Zervoudakis A,
Brinton LA, Matthews CE and Gunter MJ: Reproductive and hormonal
factors and mortality among women with colorectal cancer in the
NIH-AARP Diet and Health Study. Br J Cancer. 113:562–568. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Menon U, Burnell M, Sharma A,
Gentry-Maharaj A, Fraser L, Ryan A, Parmar M, Hunter M and Jacobs
I: UKCTOCS Group: Decline in use of hormone therapy among
postmenopausal women in the United Kingdom. Menopause. 14:462–467.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rossouw JE, Anderson GL, Prentice RL,
LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA,
Howard BV, Johnson KC, et al: Writing Group for the Women's Health
Initiative Investigators: Risks and benefits of estrogen plus
progestin in healthy postmenopausal women: Principal results From
the Women's Health Initiative randomized controlled trial. JAMA.
288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Beral V, Banks E, Reeves G and Bull D:
Million Women Study Collaborators: Breast cancer and
hormone-replacement therapy in the Million Women Study. Lancet.
362:419–427. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beral V, Gaitskell K, Hermon C, Moser K,
Reeves G and Peto R: Collaborative Group On Epidemiological Studies
Of Ovarian Cancer: Menopausal hormone use and ovarian cancer risk:
Individual participant meta-analysis of 52 epidemiological studies.
Lancet. 385:1835–1842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Studd J: ‘PROFOX’ - the post HRT
nightmare. Climacteric. 14:217–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ayres J: Premature menopause: Management
challenges after the Women's Health Initiative. J Br Menopause Soc.
11:1572005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
(NICE) NIfHaCE, . Menopause: Diagnosis and
management (NG23) 2015. NICE guideline. Published.
12–November;2015.simplenice.org.uk/guidance/ng23
|
|
35
|
Murphy N, Strickler HD, Stanczyk FZ, Xue
X, Wassertheil-Smoller S, Rohan TE, Ho GY, Anderson GL, Potter JD
and Gunter MJ: A prospective evaluation of endogenous sex hormone
levels and colorectal cancer risk in postmenopausal women. J Natl
Cancer Inst. 107:djv2102015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Green J, Czanner G, Reeves G, Watson J,
Wise L, Roddam A and Beral V: Menopausal hormone therapy and risk
of gastrointestinal cancer: Nested case-control study within a
prospective cohort, and meta-analysis. Int J Cancer. 130:2387–2396.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yao Y, Gu X, Zhu J, Yuan D and Song Y:
Hormone replacement therapy in females can decrease the risk of
lung cancer: A meta-analysis. PLoS One. 8:e712362013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gandini S, Iodice S, Koomen E, Di Pietro
A, Sera F and Caini S: Hormonal and reproductive factors in
relation to melanoma in women: Current review and meta-analysis.
Eur J Cancer. 47:2607–2617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Micheli A, Ciampichini R, Oberaigner W,
Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta G and De
Angelis R: EUROCARE Working Group: The advantage of women in cancer
survival: An analysis of EUROCARE-4 data. Eur J Cancer.
45:1017–1027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Utsumi Y, Nakamura T, Nagasue N, Kubota H
and Morikawa S: Role of estrogen receptors in the growth of human
esophageal carcinoma. Cancer. 64:88–93. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kalayarasan R, Ananthakrishnan N, Kate V
and Basu D: Estrogen and progesterone receptors in esophageal
carcinoma. Dis Esophagus. 21:298–303. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lukits J, Remenár E, Rásó E, Ladányi A,
Kásler M and Tímár J: Molecular identification, expression and
prognostic role of estrogen- and progesterone receptors in head and
neck cancer. Int J Oncol. 30:155–160. 2007.PubMed/NCBI
|
|
43
|
Chandanos E and Lagergren J: The mystery
of male dominance in oesophageal cancer and the potential
protective role of oestrogen. Eur J Cancer. 45:3149–3155. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Egloff AM, Rothstein ME, Seethala R,
Siegfried JM, Grandis JR and Stabile LP: Cross-talk between
estrogen receptor and epidermal growth factor receptor in head and
neck squamous cell carcinoma. Clin Cancer Res. 15:6529–6540. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chang YL, Hsu YK, Wu TF, Huang CM, Liou
LY, Chiu YW, Hsiao YH, Luo FJ and Yuan TC: Regulation of estrogen
receptor α function in oral squamous cell carcinoma cells by FAK
signaling. Endocr Relat Cancer. 21:555–565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Davies L and Welch HG: Epidemiology of
head and neck cancer in the United States. Otolaryngol Head Neck
Surg. 135:451–457. 2006. View Article : Google Scholar : PubMed/NCBI
|
